Revelation Biosciences Stock Analysis

Revelation Stock Analysis Notes

The company has price-to-book ratio of 0.51. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Revelation Biosciences recorded a loss per share of 0.53. The entity had not issued any dividends in recent years. The firm had 1:30 split on the 25th of January 2024. Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. The company was founded in 2020 and is based in San Diego, California. Revelation Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 14 people. To find out more about Revelation Biosciences contact James Rolke at 650 800 3717 or learn more at https://www.revbiosciences.com.

Revelation Biosciences Investment Alerts

Revelation Biosciences Upcoming and Recent Events

Revelation Largest EPS Surprises

View All Earnings Estimates

Revelation Stock Institutional Investors

Note, although Revelation Biosciences' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Revelation Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 3.31 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Revelation Biosciences's market, we take the total number of its shares issued and multiply it by Revelation Biosciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Revelation Profitablity

Management Efficiency

Revelation Biosciences has return on total asset (ROA) of (0.6108) % which means that it has lost $0.6108 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0312) %, meaning that it created substantial loss on money invested by shareholders. Revelation Biosciences' management efficiency ratios could be used to measure how well Revelation Biosciences manages its routine affairs as well as how well it operates its assets and liabilities. As of May 24, 2024, Return On Tangible Assets is expected to decline to -0.01. The current year's Return On Capital Employed is expected to grow to -1.24. The current year's Intangible Assets is expected to grow to about 3.2 M, whereas Total Assets are forecasted to decline to about 11.6 M.

Technical Drivers

As of the 24th of May, Revelation Biosciences holds the Risk Adjusted Performance of (0.04), coefficient of variation of (1,291), and Variance of 46.54. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Revelation Biosciences, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We were able to interpolate and analyze data for thirteen technical drivers for Revelation Biosciences, which can be compared to its competitors. Please check Revelation Biosciences standard deviation, as well as the relationship between the maximum drawdown and kurtosis to decide if Revelation Biosciences is priced some-what accurately, providing market reflects its current price of 1.91 per share. Please also confirm Revelation Biosciences jensen alpha, which is currently at (0.60) to check out the company can sustain itself at a future point.

Revelation Biosciences Price Movement Analysis

Revelation Biosciences Insider Trading Activities

Revelation Biosciences Predictive Daily Indicators

Revelation Biosciences Forecast Models

Revelation Biosciences' time-series forecasting models are one of many Revelation Biosciences' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Revelation Biosciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Revelation Biosciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Revelation shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Revelation Biosciences. By using and applying Revelation Stock analysis, traders can create a robust methodology for identifying Revelation entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Revelation analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Revelation analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Revelation Biosciences stock analysis indicators help investors evaluate how Revelation Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Revelation Biosciences shares will generate the highest return on investment. By understating and applying Revelation Biosciences stock analysis, traders can identify Revelation Biosciences position entry and exit signals to maximize returns.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Revelation Biosciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. For information on how to trade Revelation Stock refer to our How to Trade Revelation Stock guide.You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

When running Revelation Biosciences' price analysis, check to measure Revelation Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revelation Biosciences is operating at the current time. Most of Revelation Biosciences' value examination focuses on studying past and present price action to predict the probability of Revelation Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revelation Biosciences' price. Additionally, you may evaluate how the addition of Revelation Biosciences to your portfolios can decrease your overall portfolio volatility.

Is Revelation Biosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Revelation Biosciences. If investors know Revelation will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Revelation Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Revelation Biosciences is measured differently than its book value, which is the value of Revelation that is recorded on the company's balance sheet. Investors also form their own opinion of Revelation Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Revelation Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Revelation Biosciences' market value can be influenced by many factors that don't directly affect Revelation Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Revelation Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Revelation Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Revelation Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.